Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Prostasol
- Development stage
- Preclinical
- Lead developer
- MedPro
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
ProstaSol is a multi-ingredient herbal dietary supplement developed by Dr. Ben Pfeifer for the complementary treatment of prostate cancer, including hormone-refractory cases. It contains a blend of plant-derived active ingredients, including flax seed lignans (LinumLife), sitosterols (Regrestrol), curcumin (BCM-95), saw palmetto, ginseng, Baikal skullcap, African prune tree, Reishi mushroom, and Japanese knotweed. The supplement is designed to reduce serum PSA levels and improve quality of life through phytoestrogenic, anti-inflammatory, antioxidant, and anti-carcinogenic mechanisms. While studied in clinical settings, it is not FDA-approved as a drug and is manufactured in the Netherlands following pharmaceutical standards for food supplements.
- Brand names
- ProstaSol
- Other names
- ProstaSol
02
Targets
COXER (Estrogen receptor)SRD5A (Steroid 5-alpha-reductase)AR (Adrenergic receptors)
Beyond the preview
Go deeper on Prostasol.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Prostasol.